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 ABSTRACT 
Numerous studies have evaluated the association between factors related to maturation and reproduction 
and breast cancer risk, but few have assessed how these factors are related to different histologic types 
of breast cancer among postmenopausal women.  We used polytomous logistic regression to assess the 
effect of age at maximum height and reproductive factors on risk of invasive breast cancer by histologic 
type in three case groups (524 ductal, 324 lobular, 196 ductal-lobular) and 469 controls enrolled in a 
population-based case-control study of women aged 55-74 years residing in the Seattle-Puget Sound 
region of Washington State (2000–2004).  Histologic type was determined by a centralized tissue review 
for 83% of cases.  Age at menarche and age at maximum height were inversely associated with risk of 
ductal-lobular carcinoma (p-value for trend=0.04 for both exposures), but not ductal or lobular carcinoma.  
Relative to nulliparous women, parous women had a 50% reduced risk of all histologic types of breast 
cancer.  We observed similar increases in risk across histologic types associated with having a first live 
birth at ≥30 years of age compared to ≤19 years of age.  Compared to parous women who never 
breastfed, those who breastfed had a reduced risk of ductal carcinoma (odds ratio=0.7, 95% confidence 
interval: 0.5-0.9), but not lobular or ductal-lobular carcinoma.  Further exploration of breast cancer risk by 
histology is merited in order to understand differences in the etiology of ductal, lobular, and ductal-lobular 
carcinoma. 
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 INTRODUCTION 
It is well established that some reproductive factors, including age at menarche, age at first full-
term pregnancy, number of live births, and breastfeeding are related to a woman’s risk of breast cancer 
(1-4).  There is also evidence that age at maximum height, as an indicator of the timing of the pubertal 
growth peak, is associated with a woman’s risk of breast cancer (5-9).  One mechanism through which all 
of these maturation and reproductive exposures influence breast cancer risk is their impact on lifetime 
number of ovulatory cycles a woman experiences.  The number of cycles a woman experiences 
influences her lifetime exposure to endogenous ovarian hormones, which is strongly related to breast 
cancer risk (2, 10).  Additionally, both pregnancy and breastfeeding induce the differentiation of breast 
epithelial cells making them less susceptible to carcinogenic insults (11-13).  
While numerous studies have evaluated the relationship between maturation and reproductive 
factors and breast cancer risk, few have assessed how they are related to different histologic types of 
breast cancer among postmenopausal women, the age group that comprises the majority of new breast 
cancer diagnoses.  Although there is evidence that ductal and lobular tumors have molecular and 
pathologic differences, as well as differences in clinical characteristics (14-21), few studies have 
examined how factors relating to maturation and reproduction may impact risk of these histologic types 
differently (6, 22-28).  Comparing results across these studies is challenging since different studies 
focused on different reproductive factors and many were heterogeneous regarding menopausal status of 
the study groups and classification of histologic case groups.  Consequently, in an effort to further 
elucidate the differences in risk factors for ductal, lobular, and ductal-lobular breast carcinomas, we 
evaluated the associations of several maturation and reproductive factors with different histologic types of 
breast cancer using data from a recently completed population-based case-control study of 
postmenopausal breast cancer that involved a centralized pathology review.  We included a 
histopathologic review of all available tissue samples in this study in order to accurately and consistently 
categorize cases by histologic type of invasive breast carcinoma.  
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 METHODS 
We utilized data from the Seattle Area Hormone and Reproductive Epidemiology Breast Cancer 
Study (SHARE), which is a population-based case-control study of invasive ductal, invasive lobular, and 
invasive ductal-lobular breast carcinoma among women 55-74 years of age living in the Seattle-Puget 
Sound region (King, Pierce, and Snohomish Counties).  This study was approved by the Fred Hutchinson 
Cancer Research Center Institutional Review Board and its methods have been described in detail 
elsewhere (29).  
Cases 
Cases were identified through the Cancer Surveillance System (CSS), a population-based cancer 
registry that is part of the Surveillance, Epidemiology, and End Results (SEER) program of the National 
Cancer Institute.  All women 55-74 years of age who were diagnosed with a primary invasive breast 
cancer from January 1, 2000 to April 31, 2004, who did not have a previous history of in situ or invasive 
breast cancer, and who had a landline home telephone were eligible for consideration as cases for this 
study.  All lobular and ductal-lobular cases that met the eligibility criteria were approached to be part of 
the study.  Since ductal cancer is the most common type of breast cancer (accounting for 70-75% of all 
cases), only a random 25% of ductal cases who met the eligibility criteria were contacted to be part of the 
study.  Ductal cases were frequency-matched to the combined lobular and ductal-lobular group 1:1 by 
five-year age groups.  A total of 1,251 cases were identified, and 83% of them were interviewed (524 
ductal, 324 lobular, and 196 ductal-lobular cases).  The reasons for eligible cases not being interviewed 
included refusal by the case or unknown location of the case (14%), death prior to interview (2%), and the 
case’s physician not allowing his/her patient to be contacted for study participation (1%).   
This study involved a centralized review of pathology reports for all cases and a centralized 
review of tumor tissue blocks for those cases with available tissue.  A two-tiered process for assigning 
histologic type was used.  Tumor tissue specimens from 869 cases (83%) were ascertained from local 
hospitals and centrally reviewed by pathologists in the Porter Laboratory at the Fred Hutchinson Cancer 
Research Center (FHCRC).  Ductal and lobular tumors were classified based on the recommendations of 
the World Health Organization (WHO) (30).  Ductal-lobular cases included cases with two separate areas 
of invasive ductal and invasive lobular tumors in the same breast and cases with one tumor with both 
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 ductal and lobular features.  One of two pathologists assessed the histology of a case based on the 
review of all slides and the diagnostic criteria.  All slides then underwent a second histology review by 
another study pathologist and any discrepancies were decided by consensus review or sent for review by 
a consultant pathologist.  There were 61 cases with discrepancies between study pathologists or between 
the review of pathology reports and the categorization based on tumor tissue review.  These cases were 
reviewed by a consultant pathologist to determine a final histology category.  For the 869 cases with 
available tumor tissue, the final histology classifications were made based on the tumor tissue review.  
When comparing the histology classifications based on tumor tissue review to those based on the review 
of pathology reports, there was 94% agreement (kappa statistic = 0.91).     
For the 175 cases for whom we could not obtain tissue, the final histologic classification was 
based upon a review of pathology reports conducted by trained abstractors.  If there were multiple 
pathology reports for a case (e.g. a biopsy report and a lumpectomy report), then the histology from the 
tumor specimen with the largest invasive component was given priority for the final histology 
classification.  Again, cases were classified as ductal-lobular only if there was documentation that the 
tumor contained both invasive ductal and invasive lobular components.  Cases with only invasive ductal 
tumors or only invasive lobular tumors were classified as ductal and lobular, respectively, regardless of 
the presence of any histologic type of in situ carcinoma.  Overall, there were 61 cases with both invasive 
ductal carcinoma and lobular carcinoma in situ who were classified as ductal cases and 63 cases with 
both invasive lobular carcinoma and ductal carcinoma in situ who were classified as lobular cases.      
Controls 
Population-based controls who were female residents of King, Pierce, and Snohomish counties 
were identified through random digit dialing (RDD) using the Mitosky-Waksberg method with a clustering 
factor of 5 (31). Using one-step recruitment, controls were frequency-matched 1:1 to the combined lobular 
and ductal-lobular case group by age (5-year age groups) and reference year (31, 32).  Among the total 
of 29,735 random telephone numbers that were called, there were 9,876 that were confirmed residential 
numbers or assumed to be residential numbers, and 87% of these numbers completed the screening 
questions for study eligibility.  A total of 660 women 55-74 years of age who had never been diagnosed 
with invasive or in situ breast cancer were identified as eligible controls and 469 (71%) were interviewed.     
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 Data Collection 
All cases and controls provided written informed consent and completed an approximately 90 
minute in-person interview with the assistance of a trained interviewer.  The interview collected 
demographic, anthropometric, reproductive, contraceptive, medical history, and lifestyle information for 
the time period prior to the reference date.  For cases, the reference date was the date of breast cancer 
diagnosis and for controls, the reference date was assigned to reflect the distribution of reference dates 
among the cases.  
With respect to our primary exposures of interest, age at menarche was grouped as ages 8-11, 
12-13, and ≥14 years.  Age at maximum height was grouped as ages ≤14, 15-16, and ≥17 years.  The 
interval between age at menarche and first live birth was grouped as 1-8, 9-12, and ≥13 years based on 
the tertile distribution of this variable.  Number of live births was classified as 1, 2, 3, and ≥4.  Age first 
breastfed was categorized as never, ≤19, 20-24, 25-29, and ≥30 years of age.  Age last breastfed was 
categorized as never, ≤24, 25-29, 30-34, and ≥35 years of age.  Age at first live birth and age at last live 
birth used the same age groupings as age first breastfed and age last breastfed, respectively.  Ever 
breastfeeding was defined as breastfeeding for at least one month.  Total breastfeeding was defined as 
total lifetime duration of breastfeeding measured in months and was grouped into the following 
categories: never, <1, 1.0-5.9, 6.0-11.9, 12.0-23.9, and ≥24.0 months. 
Data Analysis 
Polytomous logistic regression was used to compare ductal, lobular, and ductal-lobular cases to 
controls.  Odds ratios (ORs) and 95% confidence intervals (CIs) were computed as estimates of the 
relative risk, and all variables were modeled categorically.  Tests for non-linearity were conducted for 
variables with greater than two categories using a grouped linear term.  For those variables that did not 
significantly depart from linearity, a test for linear trend was conducted.  The never or zero variable 
category was excluded from the trend tests.  All tests were two-sided and p-values of <0.05 were 
considered to be statistically significant.  All analyses were adjusted for age (5-year age groups) and 
reference year.  In addition, analyses of the relationships between ever breastfeeding and duration of 
breastfeeding and breast cancer risk were adjusted for number of live births because it was a priori 
considered to be a confounder of these relationships.   
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 The variables listed in Table 1, with the exception of estrogen and progesterone receptor status, 
were systematically assessed as potential confounders of the relationships between age at maximum 
height and reproductive characteristics and risk of ductal, lobular, and ductal-lobular breast carcinoma.  In 
addition, the following variables were assessed as potential confounders: age at menopause (<47, 47-50, 
51-53, ≥54 years); income (<$20,000, $20-34,000, $35-69,000, ≥$70,000); marital status (married/living 
with male or female partner, divorced/separated, widowed, single never married); average grams of 
alcohol consumed per week (0, <24.75, ≥24.75); and smoking (ever, never).  The maturation and 
reproductive factors of interest were also assessed as potential confounders of each other.  A covariate 
was considered to be a confounder if it consistently altered the ORs across the covariate’s categories for 
each histologic type by at least 10%, if the direction of the effect of the covariate on the exposure of 
interest was plausible, and if the covariate was not another characteristic of the exposure of interest (e.g. 
age at first breastfed with a category for those who never breastfed and duration of breastfeeding with a 
never category).  None of the variables listed above or the reproductive factors of interest were found to 
be confounders of the relationship between age at menarche, age at maximum height, parity, number of 
live births, ever breastfed, or duration of breastfeeding and development of ductal, lobular, or ductal-
lobular breast carcinoma.  Age at first live birth and age first breastfed were not adjusted for each other 
because the two variables are highly correlated.  Similarly, age at last live birth and age last breastfed 
were not adjusted for each other.  Thus, all of our final analyses were adjusted for age and reference 
date, and analyses of ever breastfed and duration of breastfeeding were additionally adjusted for number 
of live births. 
For covariates hypothesized a priori as possible modifiers of effects of interest an interaction term 
was formed and tested.  If the interaction term was significant (p<0.05) for all histologic types when added 
to a model with the variable of interest, the covariate, and the matching variables, then the covariate was 
considered an effect modifier.  For age at menarche the following variables were considered as potential 
effect modifiers: number of live births, age at first live birth, ever breastfed, duration of breastfeeding, and 
age first breastfed.  For number of live births, the variables considered were age at first live birth, ever 
breastfed, duration of breastfeeding, and age first breastfed.  The potential effect modifiers considered for 
age at first live birth, age at last live birth, age first breastfed, and age last breastfed were number of live 
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 births and each other.  For ever breastfed and duration of breastfeeding we considered: number of live 
births, age at first and last live birth, and age first and last breastfed.  We did not observe statistically 
significant effect modification based on likelihood ratio testing.  All analyses were performed using Stata 
9.2 (StataCorp LP, College Station, Texas).  
Analyses of age at menarche, age at maximum height, and parity were conducted among all 
study women.  Analyses of the interval between age at menarche and age at first live birth, number of live 
births, age at first live birth, age at last live birth, ever breastfed, duration of breastfeeding, age first 
breastfed, and age last breastfed were conducted among women who reported having one or more live 
births (n=456 ductal, 277 lobular, 165 ductal-lobular, and 431 controls).  Differences in risk estimates 
across histologic type were assessed using p-values from unconditional logistic regression models that 
treated either ductal cases or lobular cases as the reference category and excluded controls.  
Specifically, a variable was created with ductal cases as the reference group and lobular and ductal-
lobular cases as separate comparison groups as well as a variable with lobular cases as the reference 
group and ductal and ductal-lobular cases as comparison groups.  These variables were then used in the 
unconditional logistic regression models from the main analyses to obtain p-values for the difference in 
risk estimates between the case groups. 
  
RESULTS 
Ductal-lobular cases were somewhat younger and more likely to have a BMI <25.0 kg/m2 
compared to ductal cases, lobular cases, or controls (Table 1).  Lobular and ductal-lobular cases were 
somewhat more likely to have graduated from college than ductal cases or controls.  Regardless of 
histologic type, cases were more likely than controls to have a first degree family history of breast cancer, 
to have experienced natural menopause, and to be current users of combined estrogen and progestin 
postmenopausal hormones.  The majority of ductal, lobular, and ductal-lobular cases had tumors that 
were estrogen receptor (ER) positive and progesterone receptor (PR) positive.  The ductal-lobular case 
group contained the greatest percentage of ER and PR positive tumors (82.6%); whereas, the ductal 
case group contained a greater percentage of ER and PR negative tumors (14.0%) than either the lobular 
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 (3.2%) or ductal-lobular (4.1%) case groups (Table 1).  Because of small numbers, the results stratified by 
ER and PR status are not presented here.         
Age at menarche was not related to risk of ductal or lobular carcinoma, but was inversely 
associated with risk of ductal-lobular carcinoma (p-value for trend=0.04, Table 2).  We compared the risk 
estimates for each histologic group to determine if they were statistically different than the risk estimates 
for other histologic groups.  We found that the risk estimate for menarche at 8-11 years of age compared 
to ≥14 years of age for ductal-lobular carcinoma was statistically different than the risk estimate for lobular 
carcinoma (p=0.02) and that the difference between the risk estimates for ductal-lobular and ductal 
carcinoma approached a statistically significant difference (p=0.05).  Women who reached their maximum 
height at an earlier age had an increased risk of ductal-lobular carcinoma (p-value for trend=0.04) 
compared to controls, however the individual risk estimates for ductal-lobular carcinoma were not 
statistically different than the risk estimates for ductal or lobular carcinoma.  We also observed a 
suggestion of an association between age when maximum height was attained and risk of ductal 
carcinoma compared to controls, but this association was within the limits of chance (p-value for 
trend=0.10).  The interval between age at menarche and first live birth was not related to risk of ductal, 
lobular, or ductal-lobular carcinoma (Table 3).   
Compared to nulliparous women, parous women had a fifty percent reduction in risk of ductal, 
lobular, and ductal-lobular carcinoma (Table 2).  Sixty to eighty percent reductions in risk of ductal, 
lobular, and ductal-lobular carcinoma were observed among women who had 2, 3, or ≥4 live births 
compared to women who had 1 live birth; however, most of these risk estimates were within the limits of 
chance (Table 3).  Women who had their first live birth when they were ≥30 years of age had increased 
risks of ductal, lobular, and ductal-lobular carcinoma compared to women who had their first live birth at 
≤19 years of age; however, this association was within the limits of chance for ductal and lobular 
carcinoma.  An older age at last live birth was associated with an increased risk of ductal-lobular (p-value 
for trend=0.01), but not with ductal or lobular carcinoma.  When comparing the risk estimates for the 
histologic case groups, we found no statistically significant differences between the risk estimates for 
each histologic type for parity, number of live births, age at first live birth, and age at last live birth.    
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 Compared to parous women who never breastfed, those who ever breastfed had a reduced risk 
of ductal carcinoma (OR=0.7, 95% CI: 0.5-0.9, Table 4), but not of lobular or ductal-lobular carcinoma, 
after adjusting for number of live births.  However, no statistically significant differences between the risk 
estimates for each histologic type were observed.  The decrease in risk of ductal carcinoma associated 
with breastfeeding was limited to women who breastfed for one month or longer, though no trend was 
observed (p-value for trend=0.43).  The risk estimate for ductal carcinoma associated with breastfeeding 
for at least 24 months (OR=0.6, 95% CI: 0.3-1.0) was significantly different (p<0.001) than the risk 
estimate for ductal-lobular carcinoma (OR=1.9, 95% CI: 1.0-3.6).  Both the ages when women first 
breastfed and last breastfed were unrelated to risk of ductal carcinoma and lobular carcinoma.  However, 
risk of ductal-lobular carcinoma increased with age last breastfed (Table 4, p-value for trend=0.004).  
Specifically, women who were ≥35 years of age when they last breastfed had a 2.3-fold (95% CI: 1.2-4.4) 
increased risk of ductal-lobular carcinoma compared to those who never breastfed and this risk estimate 
was significantly different (p=0.01) than the risk estimate for ductal carcinoma (OR=1.1, 95% CI: 0.6-1.9). 
 
DISCUSSION 
The results from this analysis should be considered within the context of the limitations of this 
study.  Among the eligible cases, 83% were interviewed and among eligible controls, 71% were 
interviewed.  If women who declined to be interviewed were different than those who participated with 
respect to the maturation and reproductive exposures of interest, then the results could be biased.  
However, an analysis of potential non-response bias from a previous case-control study of breast cancer 
found that, with the exception of height, there was little impact on the risk estimates when adding 
available data from non-respondents (33).  Exposure information was gathered via self-report and 
required the participants to remember some maturation and reproductive events that occurred many 
years earlier.  In an effort to improve the accuracy of responses, a life calendar was used to chart 
important events in a woman’s life.  If there was inaccurate recall, it is unlikely that it would differ by 
histologic case group and we expect that the resultant bias would be non-differential and thus bias our 
risk estimates toward the null.  Additionally, tumor tissue was not obtained for 17% of cases and so 
histologic classification of these cases was based only on a centralized review of pathology reports.  
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 However, this difference is unlikely to bias our results appreciably because there was 94% agreement 
between the histology classification made from the tissue review and from the pathology report review for 
the 869 cases for whom both sources of data were available. 
This is the first study to include a histopathologic review of tissue specimens and a centralized 
review of pathology reports, which allowed us to classify ductal-lobular tumors as those containing both 
an invasive ductal and invasive lobular component.  In contrast, when classification is based on 
International Classification of Diseases for Oncology (ICD-O) codes, a ductal-lobular tumor (ICD-O 
histologic code 8522) is only required to have one component, either ductal or lobular, that is invasive 
(34).  For instance, in studies using ICD-O codes to classify tumors, a tumor with an invasive ductal and a 
lobular in situ component, as well as a tumor with an invasive lobular and a ductal in situ component are 
both classified as ductal-lobular.  Additionally, some prior studies that examined histologic type of breast 
cancer by ICD-O codes included ductal-lobular tumors in the same group as invasive lobular tumors (ICD-
O histologic code 8520) (6, 23, 24).  Therefore, for both of the above reasons, our approach for 
evaluating ductal-lobular tumors was unique and provided an opportunity to assess associations that may 
have been obscured in other studies due to the heterogeneity of the tumors included in the ductal-lobular 
category. 
Both age at menarche and age at maximum height are markers of puberty, a time during which 
the breast is undergoing rapid development, and our study suggests that these ages are more strongly 
associated with risk of ductal-lobular carcinoma than with risk of ductal or lobular carcinoma.  Although 
few of the case-case comparisons yielded statistically significant differences, this could be due to the 
relatively small sample size in the ductal-lobular case group, which limited our power to detect a 
difference in ductal-lobular as compared to ductal or lobular risk estimates.  While we found that age at 
menarche was inversely associated with risk of ductal-lobular carcinoma, but not ductal or lobular 
carcinoma, other studies of primarily or only postmenopausal women have had conflicting results.  Two 
studies found a decreased risk of lobular carcinoma and not ductal carcinoma associated with a later age 
at menarche (6, 23), another found a slightly stronger decreased risk associated with ductal rather than 
lobular carcinoma (24), and a fourth study found a similar decreased risk for both ductal carcinoma and 
lobular carcinoma (25).  One of these studies excluded ductal-lobular tumors (25), while the others 
12 
 
 classified histology based on ICD-O codes, but combined the ICD-O categories for invasive lobular and 
ductal-lobular tumors because when assessed separately, there were no significant differences between 
the two categories (6, 23, 24).  In the only other study to our knowledge that assessed age at maximum 
height as a risk factor for breast cancer by histologic type among older women, Li et al. found an inverse 
association with risk of ductal,  but not lobular carcinoma; whereas, we found that age at maximum height 
was inversely associated with risk of ductal-lobular carcinoma, but not associated with risk of ductal or 
lobular carcinoma (6).  It is difficult to compare our ductal-lobular results relating to reproductive factors 
and age at maximum height to prior studies because previous studies combined the ICD-O categories for 
invasive lobular and ductal-lobular tumors (6, 23, 24), rather than separately categorizing ductal, lobular, 
and ductal-lobular tumors via a centralized tumor tissue review. 
 There is also conflicting evidence regarding differences in risk of breast cancer by histologic type 
according to other reproductive factors including parity, number of live births, and age at first live birth.  
Our results suggest that parous women have a similar reduction in breast cancer risk across ductal, 
lobular, and ductal-lobular groups compared to nulliparous women, which is consistent with one previous 
report (25), but conflicts with another study that did not find an association between parity and risk of 
ductal or lobular carcinoma (24).  We observed a suggestion of a similar risk reduction across histologic 
groups among women having two or more live births compared to those having one live birth.  Li et al. 
found similar decreased risks of ductal and lobular carcinoma for women having four or more full-term 
births compared to those having one full-term birth (24).  However, another study of older women found 
that having two or more births compared to one birth was associated with a decreased risk of ductal 
carcinoma, but not lobular carcinoma (25).  The majority of studies examining age at first live birth among 
primarily postmenopausal women have found a slightly stronger positive association with lobular 
carcinoma than ductal carcinoma for increasing age at first live birth, however the differences by histology 
were not statistically significant (6, 23, 25).  Our study, along with one other among postmenopausal 
women (24), found similar increases in risk across histologic types associated with having a first live birth 
at ≥30 years of age compared to ≤19 years of age.   
To our knowledge, only one other published study has examined the effect of breastfeeding on 
risk of different histologic types of breast cancer among postmenopausal women and it found a reduced 
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 risk of ductal carcinoma, but not lobular carcinoma among women who breastfed for at least 24 months 
compared to those who never breastfed, after accounting for number of live births (24).  We found that 
ever breastfeeding was associated with a decreased risk of ductal, but not lobular or ductal-lobular 
carcinoma compared to never breastfeeding, and that this reduction in risk was limited to women who 
breastfed for at least one month.  Though it is already established that breastfeeding reduces the risk of 
invasive breast cancer in the aggregate, our observation suggests that the cell differentiation induced by 
breastfeeding may primarily exert its protective effect on the development of invasive ductal tumors, 
rather than tumors of other histologic types.  When examining other aspects of breastfeeding, we found 
that an increasing age when last breastfed is associated with an increased risk of ductal-lobular 
carcinoma.  No other studies have assessed this association among postmenopausal women thus far, 
and this finding requires confirmation.   
Our findings suggest that early hormonal exposures associated with breast development and the 
beginning of ovulation during puberty may be associated more strongly with ductal-lobular, rather than 
with ductal or lobular carcinoma, while the cell differentiation induced by breastfeeding may be more 
strongly associated with protection against ductal, rather than lobular or ductal-lobular carcinoma.  Our 
results also suggest that ductal-lobular carcinoma has distinct risk factors differing from ductal and lobular 
carcinoma.  However, these results require replication and should be interpreted with caution considering 
the relatively small number of ductal-lobular cases in some categories and that the mechanisms 
underlying these differences are unclear.  In order to further explore the risk factors associated with 
ductal-lobular carcinoma and the potential differences in etiology compared to ductal and lobular 
carcinoma, future studies are needed that classify cases via a centralized histopathologic review of tissue 
specimens, and can thereby identify risk factors for tumors with both an invasive ductal and invasive 
lobular component. 
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 Table 1: Selected characteristics of all study women 
 Control Ductal Lobular Ductal-lobular 
 (n = 469) (n = 524) (n = 324) (n = 196) 
Characteristic n % n % n % n % 
Reference age       
55-59 137 29.2 145 27.7 92 28.4 67 34.2 
60-64 121 25.8 130 24.8 83 25.6 51 26.0 
65-69 114 24.3 132 25.2 83 25.6 43 21.9 
70-74 97 20.7 117 22.3 66 20.4 35 17.9 
Race/ethnicity*         
Non-Hispanic white 423 90.2 472 90.1 302 93.2 178 90.8 
African American 8 1.7 12 2.3 8 2.5 4 2.0 
Asian/Pacific Islander 9 1.9 18 3.4 3 0.9 6 3.1 
Native American 10 2.1 12 2.3 4 1.2 1 0.5 
Hispanic white 19 4.1 10 1.9 7 2.2 7 3.6 
Education       
1st-11th 24 5.1 37 7.1 20 6.2 9 4.6 
HS or GED 126 26.9 148 28.2 83 25.6 45 23.0 
Post HS/some college 182 38.8 185 35.3 104 32.1 72 36.7 
College grad/post college 137 29.2 154 29.4 117 36.1 70 35.7 
First degree family history of breast cancer     
No 383 84.4 401 78.6 244 76.7 147 76.6 
Yes 71 15.6 109 21.4 74 23.3 45 23.4 
Missing 15  14  6  4  
Body mass index, kg/m2       
< 25.0 180 38.5 212 40.8 130 40.5 89 46.1 
25.0 - 29.9 145 31.1 157 30.2 108 33.6 63 32.6 
≥ 30 142 30.4 151 29.0 83 25.9 41 21.2 
Missing 2  4  3  3  
Oral contraceptive duration (months)      
0 156 33.3 196 37.6 122 37.9 61 31.3 
1-59 171 36.5 178 34.2 126 39.1 78 40.0 
≥ 60 141 30.1 147 28.2 74 23.0 56 28.7 
Missing 1  3  2  1  
Menopausal status         
Natural menopause 266 58.0 349 67.8 211 67.0 133 70.4 
Simple hysterectomy 116 25.3 102 19.8 62 19.7 25 13.2 
Surgical menopause 77 16.8 64 12.4 42 13.3 31 16.4 
Missing 10  9  9  7  
Postmenopausal hormone use       
Never 94 21.3 120 24.9 52 17.0 29 15.6 
Former 103 23.4 76 15.8 41 13.4 25 13.4 
Current estrogen 149 33.8 128 26.6 82 26.9 45 24.2 
Current estrogen+progestin 95 21.5 157 32.6 130 42.6 87 46.8 
Missing 28  43  19  10  
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Estrogen and progesterone receptor status    
ER+ / PR+ – – 375 72.0 230 73.3 161 82.6 
ER+ / PR- – – 65 12.5 67 21.3 24 12.3 
ER- / PR+ – – 8 1.5 7 2.2 2 1.0 
ER- / PR- – – 73 14.0 10 3.2 8 4.1 
Missing   3 10 1  
* Non-white Hispanics (n = 6) were included in their respective racial categories. 
   
 Table 2: Relationship between reproductive factors and age at maximum height and risk of invasive ductal, lobular, and ductal-lobular 
breast carcinoma 
 
 Control Ductal  Lobular  Ductal-lobular  
 (n = 469) (n = 524)  (n = 324)  (n = 196)  
 n % n % OR† 95% CI n % OR† 95% CI n % OR† 95% CI 
Age at menarche‡        
≥ 14 106 22.6 108 20.6 1.0 Ref. 79 24.4 1.0 Ref. 31 15.9 1.0 Ref. 
12-13 260 55.4 309 59.0 1.2 0.8–1.6 177 54.6 0.9 0.6–1.3 112 57.4 1.5 0.9–2.3 
8-11 103 22.0 107 20.4 1.1 0.7–1.5 68 21.0 0.9 0.6–1.4 52 26.7 1.7 1.0–3.0* 
p for trend    p = 0.80 p = 0.60 p = 0.04 
Age at maximum height§          
≥ 17 164 35.3 146 28.3 1.0 Ref. 102 31.8 1.0 Ref. 54 28.0 1.0 Ref. 
15-16 164 35.3 206 40.0 1.4 1.0–1.9* 120 37.4 1.2 0.9–1.7 68 35.2 1.3 0.8–1.9 
≤ 14 137 29.5 163 31.7 1.3 1.0–1.8 99 30.8 1.2 0.8–1.7 71 36.8 1.6 1.0–2.4* 
p for trend    p = 0.10 p = 0.43 p = 0.04 
Parity||             
Nulliparous 36 7.7 68 13.0 1.0 Ref. 47 14.5 1.0 Ref. 28 14.3 1.0 Ref. 
Parous 433 92.3 456 87.0 0.5 0.3–0.8* 277 85.5 0.5 0.3–0.7* 168 85.7 0.5 0.3–0.8* 
* Two-sided p-value < 0.05 
† OR = odds ratio comparing cases to controls using polytomous logistic regression 
‡ Adjusted for reference age and reference year. Excludes 1 woman with an unknown age at menarche.  
§ Adjusted for reference age and reference year. Excludes 19 women with an unknown age at maximum height. 
|| Adjusted for reference age and reference year. Among parous women, 5 women had only stillbirths.  
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 Table 3: Relationship between pregnancy characteristics and risk of invasive ductal, lobular, and ductal-lobular breast carcinoma, 
among women with ≥1 live births 
 
 Control Ductal  Lobular  Ductal-lobular  
 (n = 431) (n = 456)  (n = 277)  (n = 165)  
 n % n % OR† 95% CI n % OR† 95% CI n % OR† 95% CI 
Interval (years) between age at menarche and age at first live birth‡     
1-8 160 37.1 179 39.3 1.0 Ref. 93 33.6 1.0 Ref. 56 34.1 1.0 Ref. 
9-12 161 37.4 148 32.5 0.8 0.6–1.1 107 38.6 1.2 0.8–1.6 58 35.4 1.1 0.7–1.6 
≥ 13 110 25.5 129 28.3 1.1 0.8–1.5 77 27.8 1.2 0.8–1.8 50 30.5 1.3 0.8–2.1 
p for trend   p = 0.75 p = 0.30 p = 0.27 
Number of live births§       
1 42 9.7 63 13.8 1.0 Ref. 36 13.0 1.0 Ref. 20 12.1 1.0 Ref. 
2 160 37.1 145 31.8 0.6 0.4–0.9* 100 36.1 0.7 0.4–1.2 63 38.2 0.8 0.4–1.5 
3 117 27.1 124 27.2 0.6 0.4–1.0 81 29.2 0.7 0.4–1.3 44 26.7 0.8 0.4–1.4 
≥ 4 112 26.0 124 27.2 0.7 0.4–1.1 60 21.7 0.6 0.3–1.0* 38 23.0 0.7 0.4–1.3 
p for trend   p = 0.36 p = 0.11 p = 0.27 
Age at first live birth§       
≤ 19 87 20.2 104 22.8 1.0 Ref. 54 19.5 1.0 Ref. 31 18.8 1.0 Ref. 
20 - 24 216 50.1 212 46.5 0.8 0.6–1.1 130 46.9 0.9 0.6–1.4 81 49.1 1.0 0.6–1.7 
25 - 29 100 23.2 95 20.8 0.8 0.5–1.2 64 23.1 1.0 0.6–1.6 32 19.4 0.9 0.5–1.5 
≥ 30 28 6.5 45 9.9 1.4 0.8–2.5 29 10.5 1.7 0.9–3.2 21 12.7 2.1 1.0–4.3* 
p for trend    p = 0.72  p = 0.20  p = 0.24 
Age at last live birth§          
≤ 24 92 21.3 99 21.7 1.0 Ref. 58 20.9 1.0 Ref. 31 18.8 1.0 Ref. 
25 - 29 178 41.3 172 37.7 0.9 0.6–1.3 111 40.1 1.0 0.7–1.5 51 30.9 0.9 0.5–1.5 
30 - 34 110 25.5 114 25.0 1.0 0.6–1.4 71 25.6 1.0 0.7–1.6 54 32.7 1.5 0.9–2.6 
≥ 35 51 11.8 71 15.6 1.3 0.8–2.0 37 13.4 1.2 0.7–2.0 29 17.6 1.8 1.0–3.3 
p for trend    p = 0.37  p = 0.58  p = 0.01 
* Two-sided p-value < 0.05 
† OR = odds ratio comparing cases to controls using polytomous logistic regression 
‡ Adjusted for reference age and reference year. Excludes 1 woman with an unknown number of live births and 1 woman with an  
   unknown age at menarche. 
§ Adjusted for reference age and reference year. Excludes 1 woman with an unknown number of live births. 
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Table 4: Relationship between breastfeeding and risk of invasive ductal, lobular, and ductal-lobular breast carcinoma, among  
               women with ≥1 live births 
 
 Control Ductal  Lobular  Ductal-lobular  
 (n = 431) (n = 456)  (n = 277)  (n = 165)   
 n % n % OR† 95% CI n % OR† 95% CI n % OR† 95% CI 
Ever breastfed‡           
Never  140 34.7 177 42.4 1.0 Ref. 93 35.8 1.0 Ref. 54 35.8 1.0 Ref. 
Ever 264 65.3 240 57.6 0.7 0.5–0.9* 167 64.2 0.9 0.7–1.3 97 64.2 0.9 0.6–1.4 
Total breastfeeding§, months         
Never 140 32.5 177 39.0 1.0 Ref. 93 33.6 1.0 Ref. 54 32.7 1.0 Ref. 
< 1.0 27 6.3 37 8.1 1.1 0.6–1.9 17 6.1 1.0 0.5–1.9 14 8.5 1.4 0.7–3.0 
1.0 - 5.9 112 26.0 96 21.1 0.7 0.5–0.9* 65 23.5 0.9 0.6–1.3 32 19.4 0.7 0.4–1.2 
6.0 - 11.9 62 14.4 61 13.4 0.8 0.5–1.2 43 15.5 1.0 0.6–1.6 19 11.5 0.8 0.4–1.5 
12.0 - 23.9 56 13.0 58 12.8 0.8 0.5–1.3 42 15.2 1.1 0.7–1.8 24 14.5 1.1 0.6–2.0 
≥ 24.0 34 7.9 25 5.5 0.6 0.3–1.0 17 6.1 0.8 0.4–1.6 22 13.3 1.9 1.0–3.6 
p for trend††   p = 0.43 p = 0.85 p = 0.11 
Age when first breastfed||          
Never 140 34.7 177 42.2 1.0 Ref. 93 35.8 1.0 Ref. 54 35.8 1.0 Ref. 
≤ 19 43 10.6 42 10.0 0.8 0.5–1.2 23 8.8 0.8 0.4–1.4 17 11.3 1.0 0.5–1.9 
20 - 24 117 29.0 113 27.0 0.7 0.5–1.0 78 30.0 1.0 0.7–1.4 36 23.8 0.8 0.5–1.3 
25 - 29 75 18.6 55 13.1 0.6 0.4–0.9* 42 16.2 0.8 0.5–1.3 27 17.9 0.9 0.5–1.6 
≥ 30 29 7.2 32 7.6 0.9 0.5–1.6 24 9.2 1.2 0.7–2.3 17 11.3 1.5 0.7–3.0 
p for trend††    p = 0.83  p = 0.52  p = 0.35 
Age when last breastfed**          
Never 140 34.7 177 42.3 1.0 Ref. 93 35.8 1.0 Ref. 54 35.8 1.0 Ref. 
≤ 24 64 15.8 66 15.8 0.8 0.5–1.2 44 16.9 1.0 0.6–1.6 21 13.9 0.8 0.5–1.5 
25 - 29 103 25.5 73 17.5 0.5 0.4–0.8* 59 22.7 0.8 0.5–1.3 23 15.2 0.6 0.3–1.0* 
30 - 34 68 16.8 63 15.1 0.7 0.5–1.1 39 15.0 0.8 0.5–1.4 28 18.5 1.1 0.6–1.8 
≥ 35 29 7.2 39 9.3 1.1 0.6–1.9 25 9.6 1.3 0.7–2.5 25 16.6 2.3 1.2–4.4* 
p for trend††    p = 0.36  p = 0.67  p = 0.004 
* Two-sided p-value < 0.05 
† OR = odds ratio comparing cases to controls using polytomous logistic regression 
‡ Adjusted for reference age, reference year, and number of live births. Excludes 97 women with an unknown duration of breastfeeding 
   or who breastfed <1 month. 
§ Adjusted for reference age, reference year, and number of live births. Excludes 2 women with an unknown duration of breastfeeding. 
|| Adjusted for reference age and reference year. Excludes 95 women who breastfed <1 month.  
** Adjusted for reference age and reference year. Excludes 96 women with an unknown age when last breastfed or who breastfed <1 month. 
†† Test for trend excludes the never category. 
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